France· FR:67044107
AXUMIN 3200 MBq/mL solution injectable
A fluciclovine (18f) product containing fluciclovine (18f), registered in France by BLUE EARTH DIAGNOSTICS (ROYAUME UNI). The same ATC class is registered in 10 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Fluciclovine (18f) is registered in 10 of 19 countries.
Countries holding a registration under ATC V09IX12 (fluciclovine (18f)), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 7 of them publish a price we can compare per daily dose
Fluciclovine (18f) · ATC V09IX12
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- FLUCICLOVINE (18F)
- Manufacturer
- BLUE EARTH DIAGNOSTICS (ROYAUME UNI)
- Country
- France (FR)
- ATC code
- V09IX12
- ATC class
- Fluciclovine (18F)
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009550546341 flacon(s) en verre de 15 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Fluciclovine (18f) in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAXUMINBlue Earth Diagnostics Ireland Ltd, Dublin
- BelgiumRadelumin 1300 MBq/mlAbx Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien
- IrelandAxumin 1,600 MBq/mL solution for injectionBlue Earth Diagnostics Ireland Ltd
- NetherlandsAxumin 1600 MBq/ml oplossing voor injectieBlue Earth Diagnostics Ireland Ltd
- NorwayAxuminBlue Earth Diagnostics Ireland Ltd
- SwedenAxumin 1600 MBq/ml Injektionsvätska, lösningBlue Earth Diagnostics Ireland Ltd
- FinlandAxuminBlue Earth Diagnostics Ireland Ltd
- GermanyRadeluminAbx Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Radelumin
- Belgium · Radelumin
- Germany · Radelumin
- Spain · Radelumin
- Greece · Próstalumin
- Iceland · Axumin
- Italy · Radelumin
- Liechtenstein · Axumin
- Luxembourg · Radelumin
- Netherlands · Radelumin
- Norway · Axumin
- Poland · Radelumin
- Portugal · Radelumin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b5b128e2-e3f0-4047-a83d-1612e7813111 GET /v1/drugs/b5b128e2-e3f0-4047-a83d-1612e7813111?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67044107",
"date_amm": "2017-05-22",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/17/1186",
"substance": "FLUCICLOVINE (18F)",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "solution injectable",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about fluciclovine (18f).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.